Purchase the ATMP report at www.evernowpublishing.com

Subscribe to MedNous and get ahead in the business of medical innovation. Subscribe now.

The latest MedNous journal. Subscribe to download.

Sweeping change at GSK

Country: United Kingdom

GlaxoSmithKline Plc’s new chief executive plans to slim down the company’s pipeline, reduce costs and focus on respiratory medicines and treatments for HIV and infectious disease as part of a sweeping review of the company’s priorities.

Read more

Nightstar recruits executive after Series C

Country: United Kingdom

UK-based Nightstar Ltd has recruited David Lubner to its board of directors less than a month after raising $45 million in a Series C financing round to advance its lead gene therapy product for choroideremia, an inherited cause of progressive blindness.

Read more

FDA designation for Spark

Country: United States

Read more

Ablynx secures deal with Sanofi

Country: Belgium

Read more

Novartis confirms guidance

Country: Switzerland

Read more

FDA approves new adjuvant for breast cancer

Country: United States

Read more

ODAC recommends CAR-T cell therapy

Country: United States

Read more

Roche haemophilia A study in NEJM

Country: Switzerland

Read more

Targovax progresses vaccine for pancreatic cancer

Country: Norway

Read more

Sanofi to acquire Protein Sciences

Country: France

Read more

Analysis: Syncona unveils strategy after merger

Country: United Kingdom

Read more

Shire advances gene therapy

Country: Ireland

Read more

Looking for more?

Visit our news section for more articles.

News
Our full Mednous news archive
Appointments
Latest industry appointments
Events
A list of upcoming industry events

About Mednous

MedNous is a print publication and a website for everyone involved in medical research in Europe.

Read more

Free Article

Using the accelerator and brake to treat cancer, by Frédérick Triebel

Triebel LAG-3 JulAug2017.pdf

Highlights of the June 2017 MedNous issue

The June 2017 MedNous features:

Latest Mednous cover
  • Financial Strategy
    European biotechs migrate to US in search of capital
  • Interview
    How Janssen Oncology is targeting blood cancers
    Interview with Catherine Taylor
  • Clinical Strategy
    Real-world evidence is the new healthcare currency
    By Tara Raveendran
  • Adaptive Design
    AM-Pharma tests drug for acute kidney injury
  • Health Technology Assessment
    Alex Gee explains relative effectiveness
  • Therapeutic Genome Editing
    What are the risks?
    By Tim Farries and Houria Bachtarzi
  • Corporate Strategy
    Ipsen changes course
    By Robin Davison

The latest MedNous journal. Subscribe to download.